Shanghai Pharmaceuticals (02607) Releases Extraordinary General Meeting Notice

Bulletin Express
11/18

Shanghai Pharmaceuticals (02607) has announced that its Extraordinary General Meeting will be held on December 9, 2025, at 14:00. The venue is the Meeting Room on the second floor of Shanghai Pharma Building, No. 200 Taicang Road, Huangpu District, Shanghai, the People’s Republic of China.

Holders of H shares who wish to attend the meeting (in person or by proxy) should complete the reply slip, providing the shareholder’s name, address, and the number of H shares registered in their name. Completed reply slips must be delivered to Tricor Investor Services Limited at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, on or before November 28, 2025, either in person or by mail.

For shareholders intending to vote at the meeting, it is required that all transfer documents, along with the relevant share certificates, are lodged with the same registrar no later than 16:30 on December 3, 2025.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10